Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
about
Aurintricarboxylic acid is a potent inhibitor of influenza A and B virus neuraminidasesEstimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control studySafety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adultsHuman and animal sentinels for shared health risksInfluenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and SubtypesCost-effectiveness of alternative strategies for annual influenza vaccination among children aged 6 months to 14 years in four provinces in China.Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011Mutations associated with severity of the pandemic influenza A(H1N1)pdm09 in humans: a systematic review and meta-analysis of epidemiological evidence.Influenza vaccines: a moving interdisciplinary field.Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14.Early detection for cases of enterovirus- and influenza-like illness through a newly established school-based syndromic surveillance system in Taipei, January 2010 ~ August 2011Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza virusesA paradigm shift in vaccine production for pandemic influenza.Lipopeptide vaccines illustrate the potential role of subtype-crossreactive T cells in the control of highly virulent influenzaAssociation between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada.Role of CD8(+) T-cell immunity in influenza infection: potential use in future vaccine development.Influenza A viruses: why focusing on M2e-based universal vaccines.Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in EnglandInfluenza antivirals currently in late-phase clinical trial.Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010Rapid assessment of influenza vaccine effectiveness: analysis of an internet-based cohort.Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.Age-specific vaccine effectiveness of seasonal 2010/2011 and pandemic influenza A(H1N1) 2009 vaccines in preventing influenza in the United Kingdom.Effectiveness of seasonal influenza vaccines against influenza-associated illnesses among US military personnel in 2010-11: a case-control approachPandemism of swine flu and its prospective drug therapy.Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete exampleInfluenza activity in Europe during eight seasons (1999-2007): an evaluation of the indicators used to measure activity and an assessment of the timing, length and course of peak activity (spread) across Europe.Estimation of influenza vaccine effectiveness from routine surveillance data.Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine in US Children 6-35 Months of Age During 2013-2014: Results From A Phase II Randomized Trial.Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008Effectiveness of seasonal influenza vaccinations against laboratory-confirmed influenza-associated infections among Singapore military personnel in 2010-2013.Immunologic non-inferiority of a newly licensed inactivated trivalent influenza vaccine versus an established vaccine: a randomized study in US adults.Potential of the test-negative design for measuring influenza vaccine effectiveness: a systematic reviewEffectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011-2012 season in Spain, among population targeted for vaccination.A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies.Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating virusesInfluenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009.
P2860
Q21142689-5BB8E1A1-2E54-4BB4-ABE9-2B7A620D57B4Q21144621-69445EE6-F5E9-4DAD-8615-FA9E028C80A0Q26781949-C4D07D68-C6D8-4B1B-B79E-57BED1C23E9CQ28393443-8DD15B93-1309-4688-8C00-D72686632A08Q28469374-3BAB0770-B45E-421F-AE3F-5189A8AB94AFQ30217321-F9532B27-4724-481C-8E5E-B54ABEB82388Q30351995-8C5B4635-1491-4FAF-B76F-068A320833C2Q30365296-C7B00366-75DB-445E-803D-E86670461C4FQ30367695-974155AC-6D9F-4A23-AD0D-2BCE12B091BEQ30373099-C53B2B49-B5D8-4BF6-B590-43EFDB1E942AQ30373706-D62FD3F9-B435-4317-ABAB-B55BB13C036DQ30375714-DAA1CCD0-CA4C-43DF-8A9E-D2687A0612DEQ30375991-C7BCBC8E-9131-4984-801D-69104EB73DE4Q30377217-16FC7493-9207-4A92-9FF0-052728DC2CDAQ30377766-45B16E9B-B283-4015-9D00-8C46AC86CE4AQ30379213-0C6E3D06-E03F-4D56-9BF5-CDBD1545EDF7Q30388012-1FAD3FFC-CCA1-4C1C-91F8-A3157FEC52B7Q30389274-1D1D7C3B-B228-4FDB-9E74-8F49C2DEEFF4Q30396318-CA8AF2D7-3171-4864-BEFF-268692CA68FBQ30397257-A820B237-7ECE-4FB4-8F9A-9FE1886C7C26Q30398099-E6A7BAD3-DCC0-4A1A-A442-A8BFB41BD3AFQ30399334-15A445AD-3DDD-4E4B-8109-D26989C3E89EQ30404923-9900FB24-E073-4886-AF0F-A1D939AAB334Q30406933-E3A7D8F9-F57C-4857-873D-FF48E42CE99DQ30410112-3B836ACD-DAF0-4B36-9F67-A300F7D36918Q30417900-C47F017C-DAE7-46EE-82B4-0C03B22B1602Q30420024-F0F1F7A7-C5A0-44C7-B0AC-BBD73E19F3DCQ30420391-94E22C9D-E07B-47A1-B6CE-D006BCBCCF49Q30857100-FEA0509A-ED37-44A0-86A2-04753ECFF94DQ33307822-7375FE85-D1B2-4757-B98B-B9181716FFCCQ33424462-AC04356A-5CC4-4B8F-B04E-5D935C7A36FDQ33609256-25933F13-0A13-481A-91F0-569A7D8CB16AQ33931144-FB3AA7FA-DA3C-476E-900B-637383C5719AQ34274933-48784309-5407-4F26-AE0D-DBB150694187Q34706925-CB823E0C-D3EA-40ED-810C-7B4B765D8E24Q34778408-26F0FB38-9FF6-44CF-83E8-A741839656E1Q34993133-0C996AEA-5369-4481-9BC0-5CE6E08599DBQ35109002-2066ACBA-4A3C-4B2B-8F0B-F05DA1C0EEFDQ35130915-67B90A53-5312-40AF-90BE-67433B61DEB5Q35149045-B81BA603-5493-45B7-BD3C-9E7E7F791539
P2860
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@ast
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@en
type
label
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@ast
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@en
prefLabel
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@ast
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@en
P2093
P1433
P1476
Estimating vaccine effectivene ...... B vaccine mismatch in Canada.
@en
P2093
De Serres G
Sebastian R
Skowronski DM
P304
P356
10.1016/J.VACCINE.2006.10.002
P407
P577
2006-10-16T00:00:00Z